Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells - Wikidata - wikimedia - TriplyDB

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

http://www.wikidata.org/entity/Q28248489

about

Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types Radiotherapy combination opportunities leveraging immunity for the next oncology practice Targeting microRNAs as key modulators of tumor immune response Tumor-intrinsic oncogene pathways mediating immune avoidance Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment The Yin and Yang of Toll-like receptors in cancer Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions Dendritic cells: arbiters of immunity and immunological tolerance Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy Innate and adaptive immune cells in the tumor microenvironment The STING pathway and the T cell-inflamed tumor microenvironment Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models Targeting the innate immune system as immunotherapy for acute myeloid leukemia Type I interferon response and innate immune sensing of cancer Cancer immunotherapy Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.Recent advances in understanding antitumor immunity DNA sensor cGAS-mediated immune recognition Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer New perspectives on type I IFNs in cancer Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy Cancer immunotherapy via dendritic cells CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses.Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.Rational combinations of immunotherapeutics that target discrete pathways.Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells Immune Checkpoint Inhibitors: An Innovation in Immunotherapy for the Treatment and Management of Patients with Cancer.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Fatty acid-binding protein E-FABP restricts tumor growth by promoting IFN-β responses in tumor-associated macrophages.Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in mice.Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.

P2860

Q21131160-BA43E813-4A74-46CE-BF81-1E19D9720E91 Q26738443-E73435A7-5C56-40F7-A626-60045059EAE1 Q26746972-723A1D3E-FFAE-4C11-A822-8DC94485CA73 Q26747707-4EDBACBC-F0DC-47CE-AE37-06A19ADA30B0 Q26774312-C657CC01-3CBE-4EFE-BC1E-FEF6ED269F26 Q26774345-444EA2F9-36A8-4DC9-953D-C87FB31BC449 Q26775189-9EC69413-5937-4876-9AEB-4185A434673D Q26778332-C34B6E4E-B54B-4C71-9409-6A19BEE0C115 Q26796305-77FAA95C-6741-4393-B475-5DAF055EED1D Q26799117-9BDDA10C-BDF3-4A85-89F0-5939FF69D247 Q26851526-F86E4094-AFAD-44C9-8D23-0FB1A7B369B1 Q26995456-59F63B3E-0566-41D1-AF6A-963A8E8202D8 Q27001626-8E60383D-4046-485C-B677-4D1F511B3584 Q27004702-F5436AB8-51EB-4D8F-81E2-4CA49A6F5915 Q27008342-CB4757E0-9B58-4BD7-9C2A-0BCC2F2BD8F0 Q27008371-2ED38528-05AD-4FD6-B4FD-4B036C9802C9 Q27012618-B0B64A4E-E5AF-4CFC-846A-C573D73B5146 Q27015876-558D8AD0-3762-4270-A7C9-40B45130BFEF Q27023235-9C61828A-D681-4953-9A3F-716418843CB4 Q27026870-4024C86D-FD46-4526-80AD-09C0564068CA Q27340224-CE4A2516-EDFD-43F4-8F7F-70B5DA9241D4 Q28067217-81314CB9-20B8-4E68-985D-B32E47B22244 Q28073115-8D33BE23-C237-496E-87E7-415929026AB1 Q28080773-A3855119-5198-4A47-B30E-6F3C54F84E31 Q28256099-FA746C5E-D429-4A04-B8C0-19412B0F9A4B Q28304978-65F7A805-2E4A-4013-B58B-631BCA5F2A15 Q28354371-CDC739E4-7D2F-4CF5-A485-FDB13C3B8029 Q29615444-CC0C052C-C5E1-4BE4-8D3A-53094F40C90E Q30278537-82F6AC19-928D-4004-A487-4CD1D8D97D48 Q30843481-3992C4BF-19C9-4855-AAC8-6728A15E73A5 Q33606144-06DAB1F7-6BDE-44C6-9E26-22BC0280C720 Q33613138-A2A10A59-7F79-4D06-8C46-46084D6B1E71 Q33623877-DBD28FC9-6793-43E0-90D3-05D198C7B9E9 Q33633839-DA9D99EF-E08C-4D31-825C-4F2F0E8DF556 Q33659782-F14A1837-D72C-4DB1-B6B9-88A341D5FB51 Q33693183-DB0A466C-B8FD-44D7-885F-B8DDA26EE914 Q33697792-0C116831-4103-4243-BE21-1497FD263535 Q33758166-4D0BA3AB-12A8-41FB-985B-BC6A53C45D07 Q33804663-8CBAC70B-2C9F-4851-9912-46DF59B4BAE6 Q33829270-BDCEB6C9-8380-4B0D-8AB4-7CFE5C175FD1

P2860

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

http://www.wikidata.org/entity/Q28248489

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@ast

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@en

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@nl

type

label

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@ast

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@en

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@nl

prefLabel

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@ast

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@en

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@nl

P1433

Q28248489-1BA86567-807D-44EE-AA33-1B12E4740C2C

P1476

Q28248489-BAB82084-0B69-45CA-9F34-D90CBB0E96C4

P2093

Q28248489-3AD9FC21-1F72-4EB1-9698-199CDEE6E5FC

Q28248489-46841C03-0831-4E54-8BF2-08B834D865A2

Q28248489-568903DE-F964-40E2-9862-3FE7C8E22651

Q28248489-5ACA8638-2C9B-4881-90E1-31EBDD811B1F

Q28248489-7F48677F-049A-4A40-82BB-0E69BFD1B9BA

Q28248489-874F895C-C001-4B99-8C1B-61DE4BE1990A

P2860

Q28248489-03569A75-1568-4400-B375-7C36140A9BE1

Q28248489-0AF46756-360D-4D05-A73A-56638D5C8299

Q28248489-11A1012A-073D-433F-B8D0-B7D97163C8C1

Q28248489-19D4061A-6872-410B-8AED-392322B6DEDB

Q28248489-1B015E28-942B-46D5-9C63-B1859293B955

Q28248489-1B554160-BA12-4696-BE85-E38C8B33391D

Q28248489-1F3F1CE0-4EFF-4771-8E0D-4BED23D586DA

Q28248489-24CD5232-1364-466A-82D0-133CD0BAFD79

Q28248489-28B1FDFC-AC33-46A3-8D69-DBAF7DD09010

Q28248489-2B8E881F-DF33-4A41-B876-754B95B79ECF

P304

Q28248489-09BEBFBA-2A78-42BE-A7A8-DB9063C0D2CD

P31

Q28248489-072EAE35-CDC0-42A6-BA5C-29C0B51ECCC4

P3181

Q28248489-43728DB5-E6B5-47DD-9761-B349ECF06490

P356

Q28248489-69B6BDF7-58B2-4496-A22D-9B79FD4EC630

P407

Q28248489-1356663D-C97E-4DA3-BCCA-4318F677E58A

P433

Q28248489-4D606215-656C-4A81-B0C7-1EECAF7E8991

P478

Q28248489-4F918499-BF68-4C7B-ACBE-388583D45998

P50

Q28248489-66DD9163-7C2D-4103-97D1-2FD2134ECDAB

P577

Q28248489-C67DFAF1-E715-402A-9614-387162F7B411

P5875

Q28248489-A8755470-47C5-45A3-BCB6-5F3B81787F7D

P698

Q28248489-63088658-9DD5-4D84-87D4-4AE18163E07C

P932

Q28248489-DFE438A0-88C7-467A-B456-B096F421DF19

P3181

P356

P1433

Journal of Experimental Medicine

P1476

Host type I IFN signals are re ...... gh CD8{alpha}+ dendritic cells

@en

P2093

Aalok K Kacha

http://www.w3.org/2001/XMLSchema#string

David M Kranz

http://www.w3.org/2001/XMLSchema#string

Justin Kline

http://www.w3.org/2001/XMLSchema#string

Kenneth M Murphy

http://www.w3.org/2001/XMLSchema#string

Seng-Ryong Woo

http://www.w3.org/2001/XMLSchema#string

Thomas F Gajewski

http://www.w3.org/2001/XMLSchema#string

P2860

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

How cells respond to interferons

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Interferons, immunity and cancer immunoediting

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

How dying cells alert the immune system to danger

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Type I interferons in host defense

P304

2005-2016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1212793

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20101159

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Mercedes Fuertes

P577

2011-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51655021

http://www.w3.org/2001/XMLSchema#string

P698

21930765

http://www.w3.org/2001/XMLSchema#string

P932

3182064

http://www.w3.org/2001/XMLSchema#string